Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now

Blue-chip dividend stocks have always been relevant. While they’re not the most exciting investments, they provide a steady hand during market uncertainty. This attribute has…

The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.

These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?

These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?

Why Is Jaguar Health (JAGX) Stock Up 44% Today?

Jaguar Health stock is up on Tuesday as JAGX investors celebrate the company signing a new license agreement for a chemo mouth treatment.

Why Is Palisade Bio (PALI) Stock Up 57% Today?

Palisade Bio stock is up on Tuesday after the company announced positive data for its ulcerative colitis treatment PALI-2108.

Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?

Calidi Biotherapeutics stock is falling hard on Tuesday after the company priced a public offering for more than 15 million shares of CLDI.

Why Is Dynatronics (DYNT) Stock Up 93% Today?

Dynatronics stock is taking off on Tuesday morning alongside heavy trading of DYNT shares despite a lack of news from the company.

7 Consumer Discretionary Stocks Short Sellers are Betting Will Fall from Grace

Are the bears on the right or the wrong side of the trade with these seven discretionary stocks short sellers are betting against?

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns

These are the cannabis penny stocks to buy before they skyrocket on the back of robust growth and EBITDA margin expansion.

3 Pharma Stocks That Are Money-Printing Machines in 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.

BTIG Research Predicts Over 118% Rally for These 3 Stocks

Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money.

CGC Stock Alert: Canopy Growth Gets Green Light for Canopy USA

Although Canopy Growth shareholders approved a proposition to create a U.S.-focused entity, dilution risks clouded CGC stock.

Dank Dividends: 3 Cannabis REITs Offering High Yields

Cannabis REITs could see higher highs on a few key catalysts. In fact, here are three you may want to buy and hold today.

High-Flying Returns: 3 Stocks Set to Rocket From Under the Radar

Explore three undervalued stocks excelling in government services, AI, and cannabis, poised for remarkable growth.

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares…

Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?

Marinus Pharmaceuticals stock is falling on Monday with heavy trading of MRNS shares after posting an update on a Phase 3 trial.

3 Pot Stocks That Could Make You a Cannabis Millionaire

Bet on these top cannabis stocks to buy, buoyed by legalization in Germany, tax re-evaluations in Canada, and potential Florida legalization.

Why Is Soligenix (SNGX) Stock Up 58% Today?

Soligenix stock is up on Monday with heavy trading of SNGX on news of the company getting orphan drug designation from the FDA.